simoctocog alfa · Medicine question

Can simoctocog alfa increase cardiovascular risk in patients with existing cardiovascular risk factors?

Name: Can simoctocog alfa increase cardiovascular risk in patients with existing cardiovascular risk factors?
Published: 2026-11-08T02:02:03.347Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Yes, simoctocog alfa, as factor VIII replacement therapy, may increase cardiovascular risk in patients with existing cardiovascular risk factors.

Sources for this answer

Nuwiq 1500 IU powder and solvent for solution for injectionOctapharma Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 3Document updated 27 January 2025

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about simoctocog alfa